Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

Author： Abu Lila Amr   Ishida Tatsuhiro   Kiwada Hiroshi  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.27, Iss.7, 2010-07, pp. : 1171-1183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Targeting Tumor Vasculature: Reality or a Dream?

By Satchi-Fainaro Ronit  

Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. : 529-533

Informa Healthcare

Access to resources Recommend Favorite

Development of 5-FU and Doxorubicin-Loaded Cationic Liposomes against Human Pancreatic Cancer: Implications for Tumor Vascular Targeting

By Kalra Ashish   Campbell Robert  

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2809-2817

Springer Publishing Company

Access to resources Recommend Favorite

Gene delivery using cationic liposomes

By McNeil Sarah E   Perrie Yvonne  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1371-1382

Informa Healthcare

Access to resources Recommend Favorite

Clinical Use of Therapies Targeting Tumor Vasculature and Stroma

By  

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 498-508

Bentham Science Publishers

Access to resources Recommend Favorite